000 | 01912 a2200517 4500 | ||
---|---|---|---|
005 | 20250516071327.0 | ||
264 | 0 | _c20120709 | |
008 | 201207s 0 0 eng d | ||
022 | _a1525-0024 | ||
024 | 7 |
_a10.1038/mt.2011.267 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTranter, Michael | |
245 | 0 | 0 |
_aIn vivo delivery of nucleic acids via glycopolymer vehicles affords therapeutic infarct size reduction in vivo. _h[electronic resource] |
260 |
_bMolecular therapy : the journal of the American Society of Gene Therapy _cMar 2012 |
||
300 |
_a601-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aDrug Delivery Systems |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 | _aGene Silencing |
650 | 0 | 4 | _aGene Transfer Techniques |
650 | 0 | 4 |
_aHeart Ventricles _xmetabolism |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aMyoblasts, Cardiac _xmetabolism |
650 | 0 | 4 |
_aMyocardial Reperfusion Injury _xgenetics |
650 | 0 | 4 |
_aMyocytes, Cardiac _xmetabolism |
650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
650 | 0 | 4 |
_aNanoconjugates _xtherapeutic use |
650 | 0 | 4 |
_aOligodeoxyribonucleotides _xchemistry |
650 | 0 | 4 |
_aPolymers _xchemistry |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 | _aTransduction, Genetic |
700 | 1 | _aLiu, Yemin | |
700 | 1 | _aHe, Suiwen | |
700 | 1 | _aGulick, James | |
700 | 1 | _aRen, Xiaoping | |
700 | 1 | _aRobbins, Jeffrey | |
700 | 1 | _aJones, W Keith | |
700 | 1 | _aReineke, Theresa M | |
773 | 0 |
_tMolecular therapy : the journal of the American Society of Gene Therapy _gvol. 20 _gno. 3 _gp. 601-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/mt.2011.267 _zAvailable from publisher's website |
999 |
_c21407823 _d21407823 |